Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2019

01-06-2019 | Insulins | Research Article

Rice bran oil ameliorates hepatic insulin resistance by improving insulin signaling in fructose fed-rats

Authors: Mona A. Mohamed, Mervat A. Ahmed, Sohaier A. Abd Elbast, Nehad A. Ali

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2019

Login to get access

Abstract

Background

Insulin resistance is an inadequate metabolic response of the peripheral tissue to circulating insulin. It plays an important pathophysiological role in type 2 diabetes mellitus. The purpose of the study was to investigate the molecular effects of rice bran oil (RBO) on the gene expression of insulin receptor (IR), insulin receptor substrate-1 (IRS-1), glucose transporters-4 and 5 (GLUT-4 and 5) in insulin-resistant rats induced by high fructose diet (HFD).

Methods

Rats were divided into six groups (10 rats each) as follows: Groups 1 and 2: rats received a standard diet with corn oil or RBO (as the sole source of fat), respectively. Group 3: animals fed on HFD, which was furtherly divided into 2 sub-groups: rats fed HFD either for one (HFD1) or for 2 months (HFD2). Group 4, rats fed HFD containing RBO for 1 month (HFD1 + RBO), while rats in group 5 fed HFD for 30 days then RBO was added to the diet for another 30 days (HFD2 + RBO). Serum levels of glucose and insulin, as well as hepatic gene expression of insulin receptors and glucose transporters were determined. Livers were isolated for histopathological study.

Results

HFD induced insulin resistance with a reduction in the hepatic level of insulin receptor and glucose transporters at both protein and molecular levels. Addition of RBO improved the insulin sensitivity and up-regulated the expression of the tested genes.

Conclusion

HFD impaired the insulin sensitivity of the hepatocytes by down-regulating the insulin receptor genes. Addition of RBO alleviated all the hazardous effects.
Appendix
Available only for authorised users
Literature
6.
go back to reference Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86:899–906 PMID: 17921363.PubMed Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86:899–906 PMID: 17921363.PubMed
8.
go back to reference Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–43.CrossRefPubMed Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–43.CrossRefPubMed
15.
go back to reference Sharp P. Interference in glucose oxidase-peroxidase blood glucose methods. Clin Chem Acta. 1972;40:115–20.CrossRef Sharp P. Interference in glucose oxidase-peroxidase blood glucose methods. Clin Chem Acta. 1972;40:115–20.CrossRef
16.
go back to reference Dhahir FJ, Cook DB, Self CH. Amplified enzyme-linked immunoassay of human pro-insulin in serum. Clin Chem. 1992;38:227–32.PubMed Dhahir FJ, Cook DB, Self CH. Amplified enzyme-linked immunoassay of human pro-insulin in serum. Clin Chem. 1992;38:227–32.PubMed
19.
go back to reference Bezerra RM, Ueno M, Silva MS, Tavares DQ, Carvalho CR, Saad MJ. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr. 2000;130:1531–5.CrossRefPubMed Bezerra RM, Ueno M, Silva MS, Tavares DQ, Carvalho CR, Saad MJ. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr. 2000;130:1531–5.CrossRefPubMed
33.
go back to reference Nandhini AT, Anuradha CV. Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids. 2002;22:27–38.CrossRefPubMed Nandhini AT, Anuradha CV. Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids. 2002;22:27–38.CrossRefPubMed
34.
go back to reference Blakely SR, Hallfrisch J, Reiser S, Prather E. Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J Nutr. 1981;111:307–14.CrossRefPubMed Blakely SR, Hallfrisch J, Reiser S, Prather E. Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J Nutr. 1981;111:307–14.CrossRefPubMed
Metadata
Title
Rice bran oil ameliorates hepatic insulin resistance by improving insulin signaling in fructose fed-rats
Authors
Mona A. Mohamed
Mervat A. Ahmed
Sohaier A. Abd Elbast
Nehad A. Ali
Publication date
01-06-2019
Publisher
Springer International Publishing
Keywords
Insulins
Insulins
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2019
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-019-00394-2

Other articles of this Issue 1/2019

Journal of Diabetes & Metabolic Disorders 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine